Hiroshi Mabuchi
A5102695896- Venous Thromboembolism Diagnosis and Management
- Acute Ischemic Stroke Management
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cardiac tumors and thrombi
- Pulmonary Hypertension Research and Treatments
- Peripheral Artery Disease Management
- Meta-analysis and systematic reviews
Koto Hospital
2024-2025
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a life‐threatening complication post‐acute embolism (PE). The assessment of CTEPH incidence and risk factors PE in the era direct oral anticoagulants remains insufficient. Methods Results COMMAND VTE Registry‐2 (contemporary management outcomes patients with venous thromboembolism registry‐2) multicenter registry that recruited consecutive acute symptomatic from 31 centers across Japan. primary outcome was to demonstrate...
The simplified Pulmonary Embolism Severity Index (sPESI) score could help identify low-risk patients with pulmonary embolism for home treatment. However, the application of sPESI and selection treatment have not been fully evaluated in direct oral anticoagulants era.
Ischemic stroke is a serious complication in patients with cancer-associated venous thromboembolism (CAVTE), although data remain scarce the direct oral anticoagulant era.
Previous randomized clinical trials did not support a benefit of screening for occult cancer after diagnosis venous thromboembolism (VTE), although may be potential selected high-risk patients.